Page last updated: 2024-11-03

promazine and Metabolic Diseases

promazine has been researched along with Metabolic Diseases in 1 studies

Promazine: A phenothiazine with actions similar to CHLORPROMAZINE but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic.
promazine : A phenothiazine deriative in which the phenothiazine tricycle has a 3-(dimethylaminopropyl) group at the N-10 position.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huguenard, P1

Other Studies

1 other study available for promazine and Metabolic Diseases

ArticleYear
[The concept of protection in anesthesiology].
    Laval medical, 1971, Volume: 42, Issue:8

    Topics: Acidosis; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Age Factors; Aged; Analgesics;

1971